Named on 4 rounds in the feed, most often in Biotech.
Rounds from 2022-05-09 to 2025-10-07
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Celaid Therapeutics A biotechnology startup originating from the University of Tokyo and the University of Tsukuba, with proprietary technology for the selective ex vivo expansion of hematopoietic stem cells (HSCs) | Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $3.7M | 2025-10-07 | [ PART ] |
RegCell RegCell develops therapies based on regulatory T cells (Treg) to treat autoimmune diseases. | Seed Developing, 4 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | n/a | 2025-03-18 | [ LEAD ] |
Celaid Therapeutics A biotechnology startup originating from the University of Tokyo and the University of Tsukuba, with proprietary technology for the selective ex vivo expansion of hematopoietic stem cells (HSCs) | Series A ext. Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $3.0M | 2024-05-08 | [ LEAD ] |
Eureka Robotics Robotics technology company | Pre-A Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $4.3M | 2022-05-09 | [ LEAD ] |